Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aharon Lubetsky

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Thyroid : Official Journal of the American Thyroid Association|December 17, 2002
Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidismIlan Shimon, Ohad Cohen, Aharon Lubetsky, et al.
The Annals of Pharmacotherapy|October 21, 2003
Multivitamin supplements may affect warfarin anticoagulation in susceptible patientsDaniel Kurnik, Aharon Lubetsky, Ronen Loebstein, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
Potential dosing errors using portable prothrombin time monitoring devicesRonen Loebstein, Daniel Kurnik, Aharon Lubetsky, et al.
British Journal of Haematology|February 18, 2003
Diagnosis of thrombotic thrombocytopenic purpura based on modulation by patient plasma of normal platelet adhesion under flow conditionBoris Shenkman, Aida Inbal, Ilia Tamarin, et al.
Asian Cardiovascular & Thoracic Annals|July 27, 2006
Using cone and plate(let) analyzer to predict bleeding in cardiac surgeryRabin Gerrah, Alex Brill, Sagi Tshori, et al.
Archives of Internal Medicine|November 12, 2003
Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled studyAharon Lubetsky, Hagith Yonath, David Olchovsky, et al.
Thrombosis and Haemostasis|July 24, 2003
Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulationAharon Lubetsky, Yigal Shasha, David Olchovsky, et al.
Cardiology|February 14, 2021
Patent Foramen Ovale Closure among Patients with Hypercoagulable States Maintained on Antithrombotic TherapyJonathan Buber, Victor Guetta, David Orion, et al.
Human Reproduction (Oxford, England)|December 23, 2003
Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled studyHoward Carp, Rima Dardik, Aharon Lubetsky, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 14, 2012
The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution modelBoris Shenkman, Tami Livnat, Aharon Lubetsky, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Thyroid : Official Journal of the American Thyroid Association|December 17, 2002
Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidismIlan Shimon, Ohad Cohen, Aharon Lubetsky, et al.
The Annals of Pharmacotherapy|October 21, 2003
Multivitamin supplements may affect warfarin anticoagulation in susceptible patientsDaniel Kurnik, Aharon Lubetsky, Ronen Loebstein, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
Potential dosing errors using portable prothrombin time monitoring devicesRonen Loebstein, Daniel Kurnik, Aharon Lubetsky, et al.
British Journal of Haematology|February 18, 2003
Diagnosis of thrombotic thrombocytopenic purpura based on modulation by patient plasma of normal platelet adhesion under flow conditionBoris Shenkman, Aida Inbal, Ilia Tamarin, et al.
Asian Cardiovascular & Thoracic Annals|July 27, 2006
Using cone and plate(let) analyzer to predict bleeding in cardiac surgeryRabin Gerrah, Alex Brill, Sagi Tshori, et al.
Archives of Internal Medicine|November 12, 2003
Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled studyAharon Lubetsky, Hagith Yonath, David Olchovsky, et al.
Thrombosis and Haemostasis|July 24, 2003
Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulationAharon Lubetsky, Yigal Shasha, David Olchovsky, et al.
Cardiology|February 14, 2021
Patent Foramen Ovale Closure among Patients with Hypercoagulable States Maintained on Antithrombotic TherapyJonathan Buber, Victor Guetta, David Orion, et al.
Human Reproduction (Oxford, England)|December 23, 2003
Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled studyHoward Carp, Rima Dardik, Aharon Lubetsky, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 14, 2012
The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution modelBoris Shenkman, Tami Livnat, Aharon Lubetsky, et al.
Pageof 5